Page last updated: 2024-11-12

erinacine a

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

erinacine A: stimulates biosynthesis of nerve growth factor; isolated from the mushroom Hericium erinaceum [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10410568
CHEMBL ID3797576
CHEBI ID175499
SCHEMBL ID21003843
MeSH IDM000602907

Synonyms (13)

Synonym
CHEBI:175499
(3ar,5ar,6s)-3a,5a-dimethyl-1-propan-2-yl-6-[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy-2,3,4,5,6,7-hexahydrocyclohepta[e]indene-8-carbaldehyde
erinacine a
CHEMBL3797576
SCHEMBL21003843
156101-08-5
(3ar,5ar,6s)-3a,5a-dimethyl-1-(propan-2-yl)-6-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-2h,3h,3ah,4h,5h,5ah,6h,7h-cyclohepta[e]indene-8-carbaldehyde
9L2H75S9XN
cyclohept[e]indene-8-carboxaldehyde, 2,3,3a,4,5,5a,6,7-octahydro-3a,5a-dimethyl-1-(1-methylethyl)-6-(beta-d-xylopyranosyloxy)-, (3ar,5ar,6s)-
(+)-erinacin a
(3ar,5ar,6s)-2,3,3a,4,5,5a,6,7-octahydro-3a,5a-dimethyl-1-(1-methylethyl)-6-(beta-d-xylopyranosyloxy)cyclohept[e]indene-8-carboxaldehyde
HY-111954
CS-0094438

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" No adverse or test article-related differences were found in urinalysis, haematology and serum biochemistry parameters, between the treatment and control groups."( Evaluation of the toxicological safety of erinacine A-enriched Hericium erinaceus in a 28-day oral feeding study in Sprague-Dawley rats.
Chen, CC; Chen, CS; Chen, WP; Chen, YL; Lee, LY; Li, IC; Tsai, YT, 2014
)
0.67
" Conclusively, the obtained results suggested that EAHE mycelia could be relatively unharmful when used over an extended period, supporting its safe use in food preparation."( Thirteen-Week Oral Toxicity Evaluation of Erinacine AEnriched Lion's Mane Medicinal Mushroom, Hericium erinaceus (Agaricomycetes), Mycelia in Sprague-Dawley Rats.
Chen, CC; Chen, WP; Lee, LY; Li, IC; Tsai, YT; Tung, KC, 2019
)
0.78

Bioavailability

ExcerptReferenceRelevance
" HEM was cultivated via solid-state fermentation and micronized using cell wall-breaking technology to increase its bioavailability when ingested."( Antioxidative Activities of Micronized Solid-State Cultivated
Chiang, WC; Hsu, CH; Liao, EC; Wang, KL, 2023
)
0.91
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
diterpenoidAny terpenoid derived from a diterpene. The term includes compounds in which the C20 skeleton of the parent diterpene has been rearranged or modified by the removal of one or more skeletal atoms (generally methyl groups).
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID1295869Effect on neprilysin levels in cerebral cortex of APPswe/PSIdeltaE9 double transgenic C57BL/6J mouse at 30 mg/kg/day administered via oral gavage for 30 days by Western blot analysis2016Journal of natural products, Feb-26, Volume: 79, Issue:2
Erinacine S, a Rare Sesterterpene from the Mycelia of Hericium erinaceus.
AID1295867Increase in nerve growth factor levels in cerebral cortex of APPswe/PSIdeltaE9 double transgenic C57BL/6J mouse at 30 mg/kg/day administered via oral gavage for 30 days2016Journal of natural products, Feb-26, Volume: 79, Issue:2
Erinacine S, a Rare Sesterterpene from the Mycelia of Hericium erinaceus.
AID1295866Decrease in amyloid plaque burden in cerebral cortex of APPswe/PSIdeltaE9 double transgenic C57BL/6J mouse at 30 mg/kg/day administered via oral gavage for 30 days by AB10 staining based immunohistochemical assay2016Journal of natural products, Feb-26, Volume: 79, Issue:2
Erinacine S, a Rare Sesterterpene from the Mycelia of Hericium erinaceus.
AID1295868Increase in insulin degrading enzyme in cerebral cortex of APPswe/PSIdeltaE9 double transgenic C57BL/6J mouse at 30 mg/kg/day administered via oral gavage for 30 days by Western blot analysis2016Journal of natural products, Feb-26, Volume: 79, Issue:2
Erinacine S, a Rare Sesterterpene from the Mycelia of Hericium erinaceus.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (22)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's14 (63.64)24.3611
2020's8 (36.36)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 30.99

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index30.99 (24.57)
Research Supply Index3.14 (2.92)
Research Growth Index4.65 (4.65)
Search Engine Demand Index55.32 (26.88)
Search Engine Supply Index3.13 (0.95)

This Compound (30.99)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (13.64%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (86.36%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]